5 Sept 2026Open access
Exploration of novel anti-TB agents targeting the serine/threonine kinase enzyme (PknE) in Mycobacterium tuberculosis: an in silico studyPublisher siteScientific Reports, Tuberculosis Research and Epidemiology
UniversitiesAmar Mohamed Ismail
Active, last published 2026
In cancer therapeutics and mechanisms
Amar Mohamed
Ismail
Scholar“Research focused on Cancer therapeutics and mechanisms and adjacent fields.”
Al-Neelain University
Claim Your Profile5
H-index
115
Citations
Amar has not officially claimed their profile. If you are Amar, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
mar Mohamed Ismail is a researcher working on Cancer therapeutics and mechanisms. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Amar's work has been cited 115 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cancer therapeutics and mechanisms×4Bioactive Compounds and Antitumor Agents×3Tuberculosis Research and Epidemiology×2Computational Drug Discovery Methods×2Vitamin D Research Studies×2
04 · Where I am
Affiliations
Affiliation on published researchAl-Neelain UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works30 Jun 2026Open access
Factors Associated with Poor Glycemic Control and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: A Cross-sectional StudyPublisher siteSudan Journal of Medical Sciences, Adipokines, Inflammation, and Metabolic Diseases
11 May 2026Open access
The Relationship between Mannose-Binding Lectin and Diagnostic Parameters of Rheumatoid Arthritis: A Comparative StudyPublisher siteRazi Medical Journal, Complement system in diseases
26 Apr 2024Open access1cites
Novel anthraquinone amino derivatives as anticancer agents targeting the human serine/threonine kinase PAK4Publisher site4 Apr 2024Open access
Novel anthraquinone amino-derivatives as anticancer targeting human serine/threonine kinase PAK4Publisher site1 Jan 2024Open access3cites
Ethanolic Extract of <i>Mangifera indica</i> Protects against CCl<sub>4</sub>‐Induced Hepatotoxicity via Antioxidant Capabilities in Albino RatsPublisher siteJournal of Toxicology, Mangiferin and Mango Extracts
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Amar?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you